Relationship between clinical phenotypes and cognitive impairment in Parkinson's disease (PD)
- PMID: 19136159
- DOI: 10.1016/j.archger.2008.11.013
Relationship between clinical phenotypes and cognitive impairment in Parkinson's disease (PD)
Abstract
Most patients with idiopathic PD (IPD) show variable degrees of cognitive decline. The purpose of this study was to evaluate the relationship between the predominant motor symptom at the time of disease onset and the level of cognitive function in patients with IPD. A total of 159 patients with IPD were enrolled in this study. The patients' initial motor symptoms were classified into three types: tremor-dominant (TD), bradykinesia and rigidity-dominant (BRD), gait and postural instability-dominant (GPD). Disease severity was rated according to the Hoehn-Yahr classification (H&Y stage). Overall cognitive status was evaluated using the Korean versions of the Mini-Mental State Examination (K-MMSE) and the Modified Mini-Mental State (3MS) tests. The GPD group showed the lowest scores of the K-MMSE/3MS, and the patients with TD showed the best performance in the cognitive analysis (p<0.05). The patients who were older at disease onset showed worse cognitive performance than those the patients who were younger at disease onset (p<0.05). There was no difference in cognitive status according to H&Y stages. The accurate classification of initial motor symptoms and the detailed history, including the exact onset age of IPD, may allow us to predict cognitive decline in IPD.
Similar articles
-
Autonomic and cognitive functions in Parkinson's disease (PD).Arch Gerontol Geriatr. 2011 Jan-Feb;52(1):84-8. doi: 10.1016/j.archger.2010.02.005. Epub 2010 Mar 12. Arch Gerontol Geriatr. 2011. PMID: 20223528
-
Depression impairs executive functioning in Parkinson disease patients with low educational level.Cogn Behav Neurol. 2009 Sep;22(3):167-72. doi: 10.1097/WNN.0b013e3181b278f9. Cogn Behav Neurol. 2009. PMID: 19741326
-
The association between motor subtypes and psychopathology in Parkinson's disease.Parkinsonism Relat Disord. 2009 Jun;15(5):379-82. doi: 10.1016/j.parkreldis.2008.09.003. Epub 2008 Oct 31. Parkinsonism Relat Disord. 2009. PMID: 18977165
-
Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment.Mov Disord. 2009 Jun 15;24(8):1103-10. doi: 10.1002/mds.22506. Mov Disord. 2009. PMID: 19353727 Review.
-
Cognitive decline correlates with neuropathological stage in Parkinson's disease.J Neurol Sci. 2006 Oct 25;248(1-2):255-8. doi: 10.1016/j.jns.2006.05.011. Epub 2006 Jun 30. J Neurol Sci. 2006. PMID: 16814807 Review.
Cited by
-
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson's disease.J Neurol. 2014 Nov;261(11):2112-8. doi: 10.1007/s00415-014-7459-8. Epub 2014 Aug 14. J Neurol. 2014. PMID: 25119838
-
Effects of combined MAO-B inhibitors and levodopa vs. monotherapy in Parkinson's disease.Front Aging Neurosci. 2014 Jul 25;6:180. doi: 10.3389/fnagi.2014.00180. eCollection 2014. Front Aging Neurosci. 2014. PMID: 25120478 Free PMC article.
-
Dementia in long-term Parkinson's disease patients: a multicentre retrospective study.NPJ Parkinsons Dis. 2020 Jan 7;6:2. doi: 10.1038/s41531-019-0106-4. eCollection 2020. NPJ Parkinsons Dis. 2020. PMID: 31934610 Free PMC article.
-
The "brittle response" to Parkinson's disease medications: characterization and response to deep brain stimulation.PLoS One. 2014 Apr 14;9(4):e94856. doi: 10.1371/journal.pone.0094856. eCollection 2014. PLoS One. 2014. PMID: 24733172 Free PMC article.
-
Predictors of cognitive decline in the early stages of Parkinson's disease: a brief cognitive assessment longitudinal study.Parkinsons Dis. 2013;2013:912037. doi: 10.1155/2013/912037. Epub 2013 Nov 5. Parkinsons Dis. 2013. PMID: 24303226 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical